Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 5
1984 2
1985 2
1986 1
1988 2
1989 3
1990 1
1992 2
1993 2
1994 1
1995 1
1996 2
1997 2
1998 4
1999 4
2000 2
2001 2
2002 5
2003 6
2004 6
2005 2
2006 3
2007 6
2008 6
2009 2
2010 6
2011 6
2012 7
2013 11
2014 7
2015 9
2016 6
2017 14
2018 20
2019 13
2020 26
2021 21
2022 17
2023 19
2024 12
2025 23
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Röth A, He G, Tong H, Lin Z, Wang X, Chai-Adisaksopha C, Lee JH, Brodsky A, Hantaweepant C, Dumagay TE, Demichelis-Gómez R, Rojnuckarin P, Sun J, Höglund M, Jang JH, Gaya A, Silva F, Obara N, Kelly RJ, Beveridge L, Buatois S, Chebon S, Gentile B, Lundberg P, Sreckovic S, Nishimura JI, Risitano A, Han B. Röth A, et al. Among authors: obara n. Am J Hematol. 2024 Sep;99(9):1768-1777. doi: 10.1002/ajh.27412. Epub 2024 Jun 17. Am J Hematol. 2024. PMID: 38884175 Free article. Clinical Trial.
Frequent pathway mutations of splicing machinery in myelodysplasia.
Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, Sato Y, Sato-Otsubo A, Kon A, Nagasaki M, Chalkidis G, Suzuki Y, Shiosaka M, Kawahata R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Ishiyama K, Mori H, Nolte F, Hofmann WK, Miyawaki S, Sugano S, Haferlach C, Koeffler HP, Shih LY, Haferlach T, Chiba S, Nakauchi H, Miyano S, Ogawa S. Yoshida K, et al. Among authors: obara n. Nature. 2011 Sep 11;478(7367):64-9. doi: 10.1038/nature10496. Nature. 2011. PMID: 21909114
[Overview].
Obara N. Obara N. Rinsho Ketsueki. 2021;62(5):370. doi: 10.11406/rinketsu.62.370. Rinsho Ketsueki. 2021. PMID: 34108316 Japanese. No abstract available.
[Overview].
Obara N. Obara N. Rinsho Ketsueki. 2025;66(12):1566-1567. doi: 10.11406/rinketsu.66.1566. Rinsho Ketsueki. 2025. PMID: 41526261 Japanese. No abstract available.
[Acute myeloid leukemia harboring NUP98::DDX10].
Kurita N, Kato T, Nanmoku T, Maruyama Y, Suehara Y, Hattori K, Sakamoto T, Yokoyama Y, Yoshida C, Tsuboi Y, Obara N, Nishikii H, Sakata-Yanagimoto M, Chiba S. Kurita N, et al. Among authors: obara n. Rinsho Ketsueki. 2022;63(10):1397-1401. doi: 10.11406/rinketsu.63.1397. Rinsho Ketsueki. 2022. PMID: 36351646 Japanese.
[Lymphoplasmacytic lymphoma accompanied by severe myelofibrosis].
Takarada A, Momose H, Kurita N, Matsuoka R, Nakamura N, Sakamoto T, Kato T, Hattori K, Suehara Y, Yokoyama Y, Nishikii H, Maruyama Y, Obara N, Chiba S, Sakata-Yanagimoto M. Takarada A, et al. Among authors: obara n. Rinsho Ketsueki. 2023;64(1):54-59. doi: 10.11406/rinketsu.64.54. Rinsho Ketsueki. 2023. PMID: 36775308 Japanese.
[Reference guide for adult chronic neutropenia].
Yokoyama Y, Takami A, Mori Y, Sato S, Suzuki T, Gosho M, Obara N, Miyazaki Y, Akashi K, Chiba S; 日本医療研究開発機構・難治性疾患実用化研究事業「成人慢性好中球減少症の診療ガイドライン作成に向けた予後追跡調査」研究班. Yokoyama Y, et al. Among authors: obara n. Rinsho Ketsueki. 2018;59(7):845-857. doi: 10.11406/rinketsu.59.845. Rinsho Ketsueki. 2018. PMID: 30078793 Japanese.
274 results